Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells

Citation
Zh. Wang et al., Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells, ANTICANC R, 19(5B), 1999, pp. 4167-4170
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
5B
Year of publication
1999
Pages
4167 - 4170
Database
ISI
SICI code
0250-7005(199909/10)19:5B<4167:EOBABI>2.0.ZU;2-M
Abstract
Glioblastomas are the most frequent and most malignant astrocytic gliomas. The epidermal growth factor receptor (EGFR) gene is the most frequently amp lified and overexpressed in glioblastomas. The expression of bcl-2 and Bax in EGFR-antisense transfected and un-transfected glioblastoma cell line, U8 7E and U87V was studied by immunohistochemistry and western blotting. Our r esults show that the expression of Bax was stronger and bcl-2 was weaker in EGFR-antisense transfected cell line than the untransfected control. Bcl-2 and Bax genes are probably involved in the reduction of malignancy of glio blastoma cell caused by the introduction of EGFR-antisense into these tumor cells.